Michael Putman

2.5k total citations
51 papers, 962 citations indexed

About

Michael Putman is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Putman has authored 51 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Putman's work include Vasculitis and related conditions (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Michael Putman is often cited by papers focused on Vasculitis and related conditions (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Michael Putman collaborates with scholars based in United States, United Kingdom and Australia. Michael Putman's co-authors include Hironobu Sasano, Khaled Zeitoun, Serdar E. Bulun, Alan Johns, Meng Li, Bruce R. Carr, Takashi Suzuki, Nabil Moghrabi, Kazuto Takayama and Stefan Andersson and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Annals of Surgery.

In The Last Decade

Michael Putman

45 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Putman United States 13 469 334 330 194 123 51 962
Aris Daniilidis Greece 21 578 1.2× 197 0.6× 524 1.6× 56 0.3× 69 0.6× 135 1.3k
Gaspare Cucinella Italy 27 842 1.8× 150 0.4× 824 2.5× 75 0.4× 243 2.0× 109 2.0k
Panagiotis Tsikouras Greece 20 239 0.5× 163 0.5× 420 1.3× 63 0.3× 61 0.5× 142 1.4k
Mojgan Karimi‐Zarchi Iran 23 505 1.1× 170 0.5× 648 2.0× 83 0.4× 91 0.7× 138 1.9k
Carole Richard Canada 19 110 0.2× 192 0.6× 81 0.2× 209 1.1× 172 1.4× 43 1.0k
Setsuo Okada Japan 13 212 0.5× 468 1.4× 179 0.5× 55 0.3× 48 0.4× 48 1.1k
Giuseppe Gullo Italy 29 888 1.9× 223 0.7× 620 1.9× 50 0.3× 93 0.8× 135 1.9k
Giovanni Buzzaccarini Italy 19 448 1.0× 213 0.6× 308 0.9× 41 0.2× 54 0.4× 56 845
Alexander Kotlyar United States 12 936 2.0× 471 1.4× 1.0k 3.2× 47 0.2× 63 0.5× 29 1.8k
Isabel Stabile United Kingdom 16 493 1.1× 117 0.4× 324 1.0× 152 0.8× 25 0.2× 44 1.3k

Countries citing papers authored by Michael Putman

Since Specialization
Citations

This map shows the geographic impact of Michael Putman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Putman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Putman more than expected).

Fields of papers citing papers by Michael Putman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Putman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Putman. The network helps show where Michael Putman may publish in the future.

Co-authorship network of co-authors of Michael Putman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Putman. A scholar is included among the top collaborators of Michael Putman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Putman. Michael Putman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misra, Durga Prasanna, et al.. (2025). The fragility of randomized controlled trials in large vessel vasculitis. Autoimmunity Reviews. 24(12). 103917–103917. 1 indexed citations
2.
Calabrese, Leonard H., Michael Putman, Jeffrey A. Sparks, et al.. (2025). The National Academies’ 2024 Diagnostic Criteria for Long COVID : Concerns That Could Affect the Rheumatology Community. Arthritis & Rheumatology. 77(7). 785–788.
3.
4.
Duarte‐García, Alí, et al.. (2024). Incidence ofPneumocystis jiroveciiPneumonia and Prophylaxis-Associated Adverse Events Among Patients With Systemic Lupus Erythematosus. The Journal of Rheumatology. 52(1). jrheum.2023–1038.
5.
Le, Victoria, et al.. (2024). The State of Patient-Reported Outcome Measures in Rheumatology. The Journal of Rheumatology. 51(9). 920–927. 1 indexed citations
6.
Putman, Michael, et al.. (2024). Barriers to CAR T-cell therapy in rheumatology. The Lancet Rheumatology. 7(3). e212–e216. 8 indexed citations
7.
Duarte‐García, Alí, et al.. (2024). Risk of Neuroinflammatory Diseases Among New Recipients of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs. Arthritis Care & Research. 76(8). 1203–1209. 1 indexed citations
8.
Duarte‐García, Alí, et al.. (2023). Unpublished clinical trials of common rheumatic diseases. Lara D. Veeken. 62(12). 3811–3818. 4 indexed citations
9.
Sattui, Sebastian E., et al.. (2023). Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA‐Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide. Arthritis Care & Research. 76(2). 288–294. 9 indexed citations
10.
Putman, Michael, et al.. (2023). Interleukin-5 inhibition in eosinophilic granulomatosis with polyangiitis: time for another approach?. The Lancet Rheumatology. 5(12). e698–e699. 1 indexed citations
11.
Putman, Michael, et al.. (2023). Unintentional unblinding in rheumatic disease trials. The Lancet Rheumatology. 5(10). e633–e636. 2 indexed citations
12.
Coler‐Reilly, Ariella, Elizabeth R. Graef, Alfred H.J. Kim, et al.. (2022). Social media for research discourse, dissemination, and collaboration in rheumatology. PubMed. 3(4). 169–179. 6 indexed citations
13.
Sattui, Sebastian E., et al.. (2022). Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?. Seminars in Arthritis and Rheumatism. 58. 152154–152154. 3 indexed citations
14.
Putman, Michael, et al.. (2022). Any Given Monday: Association Between Desk Rejections and Weekend Manuscript Submissions to Rheumatology Journals. The Journal of Rheumatology. 49(6). 652–653. 2 indexed citations
15.
Sattui, Sebastian E., Jean W. Liew, Elizabeth R. Graef, et al.. (2020). Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Review of Clinical Immunology. 16(7). 659–666. 39 indexed citations
16.
Mackie, Sarah, Elisabeth Brouwer, Richard Conway, et al.. (2020). Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. The Lancet Rheumatology. 3(1). e71–e82. 19 indexed citations
17.
Putman, Michael, et al.. (2017). Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. The Journal of Rheumatology. 44(11). 1612–1618. 43 indexed citations
18.
Dua, Anisha B., et al.. (2016). Adult-onset Still's disease: current challenges and future prospects. Open Access Rheumatology Research and Reviews. 8. 17–17. 12 indexed citations
19.
Attar, Erkut, Hideki Tokunaga, Gonca İmir, et al.. (2008). Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis. The Journal of Clinical Endocrinology & Metabolism. 94(2). 623–631. 165 indexed citations
20.
Putman, Michael, Robert L. Burton, & Moon H. Nahm. (2005). Simplified method to automatically count bacterial colony forming unit. Journal of Immunological Methods. 302(1-2). 99–102. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aris Daniilidis Breakdown of academic impact, for papers by Gaspare Cucinella Breakdown of academic impact, for papers by Panagiotis Tsikouras Breakdown of academic impact, for papers by Mojgan Karimi‐Zarchi Breakdown of academic impact, for papers by Carole Richard Breakdown of academic impact, for papers by Setsuo Okada Breakdown of academic impact, for papers by Giuseppe Gullo Breakdown of academic impact, for papers by Giovanni Buzzaccarini Breakdown of academic impact, for papers by Alexander Kotlyar Breakdown of academic impact, for papers by Isabel Stabile
Rankless by CCL
2026